文献速递血栓与止血

高危抗磷脂综合征患者的血小板减少症

Thrombocytopenia in high-risk patients with antiphospholipid syndrome.
PubMed 文献 · J Thromb Haemost · 2018-01-25

该横断面研究分析了119例高危三阳性抗磷脂综合征(APS)患者的血小板计数,以100×10^9 L-1为界,血小板减少症患病率为6%(7例)。其中6例发生灾难性APS(CAPS),其血小板计数从基线212±51×10^9 L-1显著降至诊断时60±33×10^9 L-1,完全缓解时恢复正常(220±57×10^9 L-1)。

要点

  • 高危三阳性APS患者中血小板减少症患病率为6%(7/119),原发性与继发性APS间无差异。
  • 6例发生CAPS的患者血小板计数从基线212±51×10^9 L-1显著降至诊断时60±33×10^9 L-1。
  • 血小板计数下降总是先于CAPS完整临床表现出现。

核心结论

  • 高危APS患者中血小板减少症患病率较低。
  • 发生灾难性APS的患者均观察到血小板计数下降,且下降先于完整临床表现。
  • 高危APS患者血小板计数下降应视为疾病进展为CAPS的警告信号。

研究设计与样本

  • 横断面研究,分析119例高危三阳性APS患者的血小板计数。
  • 其中6例发生灾难性APS,记录其急性期前、急性期及恢复期的血小板计数。

主要发现

  • 119例高危三阳性APS患者平均血小板计数为210×10^9 L-1。
  • 以100×10^9 L-1为界,血小板减少症患病率为6%(7例)。
  • 原发性APS与继发性APS之间未发现差异。
  • 6例CAPS患者血小板计数从基线212±51×10^9 L-1显著降至诊断时60±33×10^9 L-1。
  • 完全缓解时血小板计数恢复正常(220±57×10^9 L-1)。

关键数值与推荐

  • 血小板减少症 cut-off 值为100×10^9 L-1。
  • 高危三阳性APS患者血小板减少症患病率为6%(7例)。
  • CAPS患者基线血小板计数212±51×10^9 L-1,诊断时60±33×10^9 L-1,完全缓解时220±57×10^9 L-1。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials The prevalence of thrombocytopenia in patients with antiphospholipid syndrome is not well defined. We studied triple positive patients with antiphospholipid syndrome and its catastrophic variant. Prevalence of thrombocytopenia was 6% and 100% in patients who developed the catastrophic form. In triple positive patients thrombocytopenia is low and platelets drop during the catastrophic form. SUMMARY: Background Thrombocytopenia is the most common non-criteria hematological feature in patients with antiphospholipid syndrome (APS). This condition is more common in patients with catastrophic APS (CAPS). Objectives To evaluate the prevalence of thrombocytopenia in a large series of high-risk patients with APS, and to assess the behavior of the platelet count during CAPS. Methods/Patients This was a cross-sectional study in which we analyzed the platelet counts of a homogeneous group of high-risk APS patients (triple-positive). Six of these patients developed a catastrophic phase of the disease, and the platelet count was recorded before the acute phase, during the acute phase, and at recovery. Results The mean platelet count in 119 high-risk triple-positive patients was 210 × 109 L-1 . With a cut-off value for thrombocytopenia of 100 × 109 L-1 , the prevalence of thrombocytopenia was 6% (seven patients). No difference between primary APS and secondary APS was found. In patients who suffered from CAPS, a significant decrease from the basal count (212 ± 51 × 109 L-1 ) to that at the time of diagnosis (60 ± 33 × 109 L-1 ) was observed. The platelet count became normal again at the time of complete remission (220 ± 57 × 109 L-1 ). A decrease in platelet count always preceded the full clinical picture. Conclusions This study shows that, in high-risk APS patients, the prevalence of thrombocytopenia is low. A decrease in platelet count was observed in all of the patients who developed the catastrophic form of the disease. A decrease in platelet count in high-risk APS patients should be considered a warning signal for disease progression to CAPS.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Pontara E, Banzato A, Bison E, et al. Thrombocytopenia in high-risk patients with antiphospholipid syndrome. J Thromb Haemost. 2018. PMID: 29316193. doi:10.1111/jth.13947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。